Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
288 participants
INTERVENTIONAL
2020-02-04
2021-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3D Maternal Fetal Attachment and Smoking
NCT04541121
Third Trimester 3D Printed Models Versus 3D Ultrasound Effects on Maternal-Fetal Attachment
NCT03883971
Fetal Anatomy by Three-Dimensional Ultrasound
NCT00340002
The Value of Prenatal Ultrasound in Complicated Twin Pregnancy and Its Correlation With Chromosomal Anomalies
NCT02732717
Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complications
NCT06935422
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3D printed model
Mother or Mother/Father is given 3D printed model of fetus' face
3D printed model
Mother or Mother/Father is given 3D printed model of fetus' face
Placebo
Mother or Mother/Father is given printed picture of 3D ultrasound of fetus
Placebo
Mother or Mother/Father is given a picture of 3D ultrasound of fetus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D printed model
Mother or Mother/Father is given 3D printed model of fetus' face
Placebo
Mother or Mother/Father is given a picture of 3D ultrasound of fetus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently pregnant (\< 32 weeks gestation)
* Have normal 20-week ultrasound
Exclusion Criteria
* Medical need for additional ultrasounds
* Multiple fetuses
* \> 31 weeks gestation
19 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Creighton University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Cote, MD
Role: PRINCIPAL_INVESTIGATOR
Creighton University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Creighton University
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1052761
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.